Synthesis, Anticancer Activity, Structure-Activity Relationship, and Molecular Modeling Studies of α-Mangostin Derivatives as hERα Inhibitor.


Journal

Journal of chemical information and modeling
ISSN: 1549-960X
Titre abrégé: J Chem Inf Model
Pays: United States
ID NLM: 101230060

Informations de publication

Date de publication:
14 Nov 2022
Historique:
pubmed: 3 12 2021
medline: 16 11 2022
entrez: 2 12 2021
Statut: ppublish

Résumé

α-Mangostin is one of the secondary metabolites in mangosteen pericarp, which has been reported to have anti-breast cancer activity. In our previous study, three α-mangostin derivatives were computationally designed as hERα antagonists. In this present study, the designed compounds were synthesized undergoing a benzoylation reaction between α-mangostin with three benzoyl chloride derivatives to produce three derivatives, namely,

Identifiants

pubmed: 34854302
doi: 10.1021/acs.jcim.1c00926
doi:

Substances chimiques

mangostin U6RIV93RU1
Xanthones 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5305-5316

Auteurs

Richa Mardianingrum (R)

Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Sumedang 45363, West Java, Indonesia.
Pharmacy Program, Faculty of Health Science, Universitas Perjuangan, Tasikmalaya 46115, West Java, Indonesia.

Maywan Hariono (M)

Faculty of Pharmacy, Sanata Dharma University, Depok, Sleman 55282, Yogyakarta, Indonesia.

Ruswanto Ruswanto (R)

Pharmacy Program, STIKes Bakti Tunas Husada, Tasikmalaya 46115, West Java, Indonesia.

Muhammad Yusuf (M)

Department of Chemistry, Faculty of Mathematics and Natural Sciences, Padjadjaran University, Jatinangor, Sumedang 45363, West Java, Indonesia.

Muchtaridi Muchtaridi (M)

Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Sumedang 45363, West Java, Indonesia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH